Janux Therapeutics JANX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Janux Therapeutics's short-term investments?
- Janux Therapeutics (JANX) reported short-term investments of $904.56M in Q1 2026.
- How has Janux Therapeutics's short-term investments changed year-over-year?
- Janux Therapeutics's short-term investments decreased by 3.8% year-over-year, from $940.4M to $904.56M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.